GGrantIndex
Sort

53,477 grants matching addiction

Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms

$1,981,761
Michael Michaelides · National Institute On Drug Abuse · ZIA · FY2022 · DA

Molecular Pathogenesis of Multiple Myeloma

$1,979,910
Walter Michael Kuehl · Clinical Sciences · Z01 · FY2007 · CA

Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-55

$1,979,658
Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2012 · DA

Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-55

$1,979,657
Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2014 · DA

Human Microphysiological Model of Afferent Nociceptive Signaling

$1,978,863
Michael J Moore · Tulane University Of Louisiana · UH3 · FY2021 · TR

NIDA Clinical Trials Network: Greater New York Node

$1,974,434
John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA

Center for Opioid and Cocaine Addiction (COCA)

$1,973,263
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2019 · DA

Development of novel therapeutics for opioid dependence

$1,972,485
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UG3 · FY2019 · DA

Development of novel therapeutics for opioid dependence

$1,972,485
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2021 · DA

Development of novel therapeutics for opioid dependence

$1,972,485
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2020 · DA

Development of novel therapeutics for opioid dependence

$1,972,485
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2022 · DA

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness

$1,970,462
Katherine E Watkins · Rand Corporation · UF1 · FY2020 · MH

Clinical Trials Network: Greater New York Node

$1,970,018
Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2015 · DA

Activity-dependent Synaptic and Circuit Plasticity

$1,967,629
Robert C Malenka · Stanford University · P50 · FY2016 · MH

A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail

$1,967,149
Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2023 · DA

The National Drug Abuse Clinical Trials Network: New England Consortium Node

$1,964,502
Gail D'onofrio · Yale University · UG1 · FY2022 · DA

Scientific and Statistical Computing Core

$1,962,771
Robert Cox · National Institute Of Mental Health · ZIC · FY2020 · MH

Assessment,Treatment, and Pharmacological Interventions in Alcoholic Patients

$1,962,689
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Microdialysis Studies of Self-administrationx

$1,962,393
Roy A Wise · National Institute On Drug Abuse · ZIA · FY2013 · DA

Center for Opioid and Cocaine Addiction (COCA)

$1,960,371
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2022 · DA

Center for Opioid and Cocaine Addiction (COCA)

$1,960,371
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2021 · DA

Characterization of neuronal ensembles activated during drug-induced behavior

$1,960,065
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2014 · DA

Dynamic mapping of the complete synaptome using recombinant probes

$1,960,006
Donald B Arnold · University Of Southern California · R01 · FY2017 · MH

Dynamic mapping of the complete synaptome using recombinant probes

$1,960,006
Donald B Arnold · University Of Southern California · R01 · FY2016 · MH

Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-55

$1,959,860
Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2016 · DA